This bill enacts new provisions to the Uniform Controlled Dangerous Substances Law in Louisiana by adding specific substances to Schedule I and Schedule E. The new entries include N-Desethyl isotonitazene (N-ethyl-2-[(4-isopropoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine) and Etonitazepipne (2-[(4-ethoxyphenyl)methyl]-5-nitro-1-[2-(piperidin-1-yl)ethyl]-1H-benzimidazole) under Schedule I, as well as Ethylphenidate under Schedule E.

Additionally, the bill authorizes the Louisiana State Law Institute to renumber these new entries to ensure they are organized in alphabetical order. This legislative action aims to address the regulation of these substances, which may have implications for public health and safety.